SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-072781
Filing Date
2015-12-24
Accepted
2015-12-24 13:01:20
Documents
4
Period of Report
2015-12-18
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v427791_8k.htm 8-K 19448
2 EXHIBIT 16.1 v427791_ex16-1.htm EX-16.1 4273
3 GRAPHIC image_004.jpg GRAPHIC 2636
4 GRAPHIC image_005.jpg GRAPHIC 4617
  Complete submission text file 0001144204-15-072781.txt   35303
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 151307737
SIC: 2834 Pharmaceutical Preparations